Researchers continue to investigate why some people develop plaque psoriasis, an autoimmune disease that results in the overproduction of skin cells. These extra cells rapidly pile up on the skin ...

Treatment with TNF inhibitors may be beneficial over phototherapy in reducing the risk for psoriatic arthritis in patients ...

A new analysis highlights the effectiveness of risankizumab in patients with moderate plaque psoriasis and those newly classified as systemic therapy eligible under International Psoriasis Council ...

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in high-impact areas.

Guselkumab significantly improves psoriasis severity and quality of life compared with placebo in patients with skin of color.

One of the more serious side effects from immune checkpoint inhibitor (ICI) therapies for cancer is new-onset or worsened ...

For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

Early biologic response patterns in plaque psoriasis revealed faster remission with anti-IL-17AF and underscored the need for tailored treatment strategies.

There’s a new ‘bonus’ tax deduction worth $6,000 for older taxpayers — here’s who qualifies ...

The likelihood of reduced quality of life and high symptom burden in patients with psoriasis was similar across those with low, medium, and high BSA.

Psoriatic arthritis (PsA) is less common among Black people compared to other races, but differences in prevalence may also ...

Psoriasis causes patches of dry, itchy skin that can crack and bleed, increasing your risk for infection. Learn how to prevent and treat psoriasis fissures.